Asacol 400 mg gastrorezistentne tablete Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

asacol 400 mg gastrorezistentne tablete

tillotts pharma gmbh - mesalazin - gastrorezistentna tableta - mesalazin 400 mg / 1 tableta - mesalazin

Asacol 800 mg gastrorezistentne tablete Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

asacol 800 mg gastrorezistentne tablete

tillotts pharma gmbh - mesalazin - gastrorezistentna tableta - mesalazin 800 mg / 1 tableta - mesalazin

Asacol 800 mg gastrorezistentne tablete Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

asacol 800 mg gastrorezistentne tablete

tillotts pharma gmbh - mesalazin - gastrorezistentna tableta - mesalazin 800 mg / 1 tableta - mesalazin

Budezonid Ferring 9 mg tablete s podaljšanim sproščanjem Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

budezonid ferring 9 mg tablete s podaljšanim sproščanjem

ferring gmbh - budezonid - tableta s podaljšanim sproščanjem - budezonid 9 mg / 1 tableta - budezonid

Dasatinib Accordpharma Evropska unija - slovenščina - EMA (European Medicines Agency)

dasatinib accordpharma

accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastična sredstva - dasatinib accordpharma is indicated for the treatment of adult patients with: newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase.  chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib.  ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy. dasatinib accordpharma is indicated for the treatment of paediatric patients with: newly diagnosed ph+ cml in chronic phase (ph+ cml-cp) or ph+ cml-cp resistant or intolerant to prior therapy including imatinib.  newly diagnosed ph+ all in combination with chemotherapy.